Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Hits & Misses
    • Artificial Intelligence and Healthcare
    • Doctors & Hospitals
      • COVID-19 and Public Health
    • Policy & Legislation
      • Affordable Care Act
    • Health Economics & Costs
      • Cost of Healthcare
      • Drug Prices & Regulations
      • Health Reform
    • Health Insurance
      • Public Insurance
      • Medicare
    • Telemedicine
      • Medical Tourism
  • Goodman Institute
  • Contact
  • Search
The Goodman Institute Health Blog

Author: Devon Herrick

The FTC wants to Know if Middlemen Increase Drug Prices

Posted on June 8, 2022June 8, 2022 by Devon Herrick

The Federal Trade Commission (FTC) is opening an investigation into the business practices of pharmacy benefit managers (PBMs). PBMs have been in the hotseat for quite some time. Executives from the largest PBMs were recently called to testify before Congress to explain whether their business practices lead to higher drug prices. In the latest inquiry, the FTC announced it will require the six largest PBMs to provide a range of information and business records on operations.

+

Is it OK for Apple and Walmart Associates to be on Medicaid?

Posted on June 7, 2022 by Devon Herrick

The CEO of L.A. Care Health Plan recently blogged about walking into an Apple store in downtown Los Angeles and discovering the sales associate who assisted him was a client. L.A. Care is a purveyor of both Medicaid managed care plans and Obamacare plans sold on the Covered California health insurance marketplace. He was aghast when the sale associate said she was covered through Medi-Cal, the California Medicaid program.

+

Who Does the AARP Represent?

Posted on June 6, 2022 by Devon Herrick

The AARP, the legendary advocacy for seniors aged 50 and above, has come under increased scrutiny in recent years for its marketing partnerships. Much of AARP’s revenue comes from licensing its name and logo to sell a wide range of goods and services targeted to seniors. The AARP is undoubtedly a senior advocacy, but it is also a marketing juggernaut that sells insurance.

+

Aging Colons a Goldmine for Private Equity Investors

Posted on June 3, 2022 by Devon Herrick

Private equity investors are increasingly buying gastroenterology practices. Around 1,400 of the nation’s gastroenterologists are employees or partners in practices backed by private equity. According to a recent whitepaper, acquisitions of gastroenterology practices by private equity grew by 28% last year. As one investment manager noted:

We are in the Golden Age of older rectums—from a supply side, at least. Elderly people will make up 20% of the population by 2030, and health care costs are projected to approach 20% of the nation’s gross domestic product—the highest in the world, according to the U.S. Census Bureau. It would seem a boom time for gastroenterologists.

+
  • Previous
  • 1
  • …
  • 195
  • 196
  • 197
  • 198
  • 199
  • 200
  • 201
  • …
  • 210
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 43 other subscribers

Popular Topics

©2026 The Goodman Institute Health Blog | Website by Lexicom